CompletedPhase 2NCT00694629
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
Studying Primary pulmonary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centers for Disease Control and Prevention
- Principal Investigator
- Susan Dorman, MDJohns Hopkins University
- Intervention
- rifampin(drug)
- Enrollment
- 865 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2013
Study locations (29)
- Central Arkansas Veterans Health System, Little Rock, Arkansas, United States
- LA County/USC Medical Center, Los Angeles, California, United States
- University of Southern California Medical Center, Los Angeles, California, United States
- University of California at San Diego, San Diego, California, United States
- University of California, San Francincisco, San Francisco, California, United States
- Denver Department of Public Health and Hospitals, Denver, Colorado, United States
- Washington DC Veterans Administration Medical Center, Washington D.C., District of Columbia, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States
- Northwestern University, Chicago, Illinois, United States
- Hines VA Medical Center, Hines, Illinois, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- Boston Medical Center, Boston, Massachusetts, United States
- New Jersey Medical School, Newark, New Jersey, United States
- Columbia University/Presbyterian Medical Center, New York, New York, United States
- +14 more locations on ClinicalTrials.gov
Collaborators
Sanofi
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00694629 on ClinicalTrials.govOther trials for Primary pulmonary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07517445Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGPHASE2NCT07525427Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary TuberculosisGates Medical Research Institute
- RECRUITINGNANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University
- RECRUITINGPHASE3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGPHASE2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPHASE2NCT06192160Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science
- ACTIVE NOT RECRUITINGNANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University